Kronox Lab Sciences Ltd (KRONOX) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Kronox Lab Sciences Ltd on NSE and BSE, with an AI summary of each filing.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 05 Nov 2026, 5:30 am
Kronox Lab Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited Standalone Financial ....
Intimation · 05 Nov 2026, 5:30 am
Kronox Lab Sciences Board to Consider Q2 FY27 Results on 5th Nov'26 Kronox Lab Sciences Limited has scheduled its Board of Directors meeting for 5th Nov'26 to consider and approve the unaudited standalone financial results for the quarter and half year ended 30th Sep'26. Additionally, the trading window for dealing in company securities by designated persons has been closed since 1st Oct'26 and will reopen 48 hours after the formal declaration of the financial results.
KRONOX LAB SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 05 Nov 2026, 5:30 am
IIFL Capital Services Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer to the Public Shareholders of Kronox Lab Sciences Ltd ("Target Company").
Others (Uncategorized) · 29 Oct 2026, 10:50 pm
Disclosure under Regulation 30A of SEBI (LODR) - Amendment of the Share Purchase Agreement
Others (Uncategorized) · 23 Oct 2026, 10:18 pm
Kronox Lab Sciences Discloses Share Purchase Agreement Amendment Removing Seller Share Lock-In Kronox Lab Sciences announced that Indo Borax & Chemicals, Zenrock Chemicals, and erstwhile promoters entered into an amendment agreement on 22nd Oct'26 regarding the original SPA dated 20th Aug'26. Indo Borax holds a 64.26% stake and assumed promoter status on 29th Sep'26, while the erstwhile sellers retain 9.95%. The amendment entirely removes Clause 9.5 (share lock-in) and Clause 9.6 (right of first refusal), allowing the erstwhile sellers to freely trade their retained shareholding without restrictions.
Outcom of Board Meeting held on October 14, 2026 to discuss agenda for acquition of Plant at Dahej, SEZ
Others (Uncategorized) · 14 Oct 2026, 10:27 pm
Kronox Lab Sciences Approves Acquisition of Manufacturing Plant in Dahej SEZ Kronox Lab Sciences' Board approved the acquisition of a chemical manufacturing plant spanning ~5,000 sq. meters from Axiom Chemicals at Dahej SEZ on 14th Oct'26. The asset purchase aims to expand manufacturing capacity for business growth. The transaction is structured as an all-cash deal funded via internal accruals and is not a related-party transaction. The acquisition is targeted for completion within one month, subject to regulatory clearances, including approvals from the Development Commissioner/SEZ authority, State Pollution Control Board, and GIDC.
Acquition of a Plant adm. about 5000 Sq. Meters located in Dahej SEZ fromAxiom Chemicals Private Limited
Others (Uncategorized) · 14 Oct 2026, 10:24 pm
Kronox Lab Sciences Acquires 5,000 Sqm Dahej SEZ Plant to Expand Capacity On 14th Oct'26, Kronox Lab Sciences approved the acquisition of a chemical manufacturing plant admeasuring approximately 5,000 sq. meters located at Dahej SEZ from Axiom Chemicals Private Limited. The transaction involves purchasing the physical asset/plant rather than shares, aimed at expanding manufacturing capacity. Funded entirely via internal accruals through cash consideration, the non-related-party deal is expected to close within one month, subject to regulatory approvals from SEZ authorities, the State Pollution Control Board, and execution of definitive agreements.
Disclosure under Regulation 7(2) of SEBI (PIT) Regulations, 2015 - Informatioin and Update
Others (Uncategorized) · 01 Oct 2026, 10:55 pm
Kronox Lab Sciences Promoters Offload 64.26% Stake Via SPA Pursuant to an SPA dated 20th Aug'26, promoters Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani executed off-market stake sales on 29th Sep'26. Indo Borax & Chemicals Limited and Zenrock Chemicals Private Limited acquired an aggregate 2,38,44,000 equity shares (64.26% of paid-up capital) at Rs 103.22 per share. Jaswal and Ketan Ramani each sold 85,66,400 shares (reducing stakes from 26.40% to 3.31%), while Pritesh Ramani sold 67,11,200 shares (reducing stake from 21.40% to 3.31%), leaving each promoter with 12,30,000 shares post-transaction.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo Borax & Chemicals Ltd & PAC
Acquisition/ Disposal of Shares · 30 Sept 2026, 8:51 pm
Indo Borax Acquires Controlling Stake in Kronox Lab Sciences Pritesh Vinodchandra Ramani sold 67,11,200 equity shares (18.10% stake) of Kronox Lab Sciences Limited off-market on 29th Sep'26, reducing his holding from 21.40% (79,41,200 shares) to 3.32% (12,30,000 shares). The transaction executed a Share Purchase Agreement dated 20th Aug'26, under which Acquirer Indo Borax & Chemicals Limited, alongside PAC Zenrock Chemicals Private Limited, directly acquired 2,38,44,000 equity shares in aggregate, securing a 64.26% voting right to become the new promoter of Kronox Lab Sciences. Total paid-up equity capital stands at INR 37.10 cr.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo Borax & Chemicals Ltd & PAC
Acquisition/ Disposal of Shares · 30 Sept 2026, 8:32 pm
Indo Borax & Chemicals Acquires Controlling Stake in Kronox Lab Sciences Pursuant to an SPA dated 20th Aug'26, Indo Borax & Chemicals acquired 85,66,400 equity shares (23.088% stake) of Kronox Lab Sciences from seller Jogindersingh Gianchand Jaswal on 29th Sep'26 via an off-market transaction. Jaswal's holding reduced from 26.40% (97,96,400 shares) to 3.32% (12,30,000 shares). In aggregate, Indo Borax acquired 2,38,44,000 shares from the promoter group, securing a 64.26% voting stake to become the promoter of Kronox Lab Sciences.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo Borax & Chemicals Ltd & PAC
Acquisition/ Disposal of Shares · 30 Sept 2026, 6:22 pm
Indo Borax & Chemicals Acquires Controlling Stake in Kronox Lab Sciences Pursuant to a Share Purchase Agreement dated 20th Aug'26, promoter Ketan Vinodchandra Ramani offloaded 85,66,400 equity shares (23.088% stake) in Kronox Lab Sciences Limited on 29th Sep'26, reducing his holding from 26.40% (97,96,400 shares) to 3.32% (12,30,000 shares). Through aggregate acquisitions totaling 2,38,44,000 shares from promoters, Indo Borax & Chemicals Limited alongside PAC Zenrock Chemicals has secured 64.26% voting rights, taking over as the new promoter of the company. Total paid-up equity remains INR 37.10 crore across 3,71,04,000 shares.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo Borax & Chemicals Ltd & PACs
Acquisition/ Disposal of Shares · 30 Sept 2026, 4:48 pm
Indo Borax & Chemicals Acquires 64.26% Stake in Kronox Lab Sciences Indo Borax & Chemicals Limited has acquired 2,38,44,000 equity shares, representing a 64.26% stake, in Kronox Lab Sciences Limited on 29th Sep'26. The off-market transaction was executed pursuant to a Share Purchase Agreement dated 20th Aug'26 with sellers Ketan Vinodchandra Ramani, Pritesh Vinodchandra Ramani, and Jogindersingh Gianchand Jaswal. Following the acquisition, Indo Borax & Chemicals gains sole control and becomes the promoter of Kronox Lab Sciences, alongside Person Acting in Concert (PAC) Zenrock Chemicals Private Limited. Kronox Lab's total paid-up equity capital stands at INR 37.10cr.
The Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indo Borax & Chemicals Ltd & PACs
Others (Uncategorized) · 30 Sept 2026, 4:46 pm
Indo Borax & Chemicals Acquires 64.26% Stake in Kronox Lab Sciences Indo Borax & Chemicals Limited acquired 2,38,44,000 equity shares of Kronox Lab Sciences Limited on 29th Sep'26, representing a 64.26% stake in the target company's total voting capital. The off-market transaction was executed pursuant to a Share Purchase Agreement dated 20th Aug'26 at a purchase price of INR 103.22 per share. Prior to this acquisition, the acquirer and person acting in concert, Zenrock Chemicals Private Limited, held zero shares in Kronox Lab Sciences.
Disclosure under Regulation 30, 30A and any other applicable provision of SEBI LODR read with SEBI Master Circular dated January 30, 2026
Change in Management · 30 Sept 2026, 12:19 am
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences Amid Board Overhaul Kronox Lab Sciences promoters completed the transfer of 2,38,44,000 shares (64.26% stake) to Indo Borax & Chemicals on 29th Sep'26, reducing their holding to 9.95% and relinquishing promoter status. Concurrently, Suresh Kalra was appointed MD & CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO, alongside a broad reconstitution of board committees. The outgoing promoters—Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani—resigned from their executive roles and signed 36-month transition consultancy agreements with the company for ₹2.10 crore each.
Disclosure under Regulation 30, 30A and any other applicable provisions of SEBI LODR read with Master Circular dated January 30, 2026
Change in Management · 30 Sept 2026, 12:15 am
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences Amid Leadership Overhaul Sellers transferred a 64.26% stake (2,38,44,000 shares) in Kronox Lab Sciences to Indo Borax & Chemicals on 29th Sep'26, reducing seller holding to 9.95% and reclassifying them out of the promoter group. Concurrently, Suresh Kalra was appointed MD & CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO. Outgoing promoters Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani resigned from the board and entered 36-month transition consultancy agreements with the company for an aggregate fee of ₹2.10 crore each.
Disclosure under Regulation 30, 30A and other applicable provisions of SEBI LODR read with Master Circular Date 30 January, 2026
Change in Management · 30 Sept 2026, 12:07 am
Kronox Lab Sciences Completes 64.26% Stake Sale and Overhauls Leadership Kronox Lab Sciences announced that sellers completed the transfer of 2,38,44,000 shares (64.26% stake) to Indo Borax & Chemicals on 29th Sep'26 under their SPA. Sellers retain a 9.95% stake and cease to be promoters. Following the change of control, the board reconstituted entirely: Suresh Kalra was appointed MD & CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO. Outgoing promoters Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani resigned from executive roles and entered 36-month transition consultancy agreements at ₹2.10 crore each.
Disclosure under Regulation 30, 30A and any other Applicable provisions of SEBI LODR read with Master Circular dated January 30, 2026.
Change in Management · 30 Sept 2026, 12:05 am
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences On 29th Sep'26, Indo Borax & Chemicals Limited completed the acquisition of 2,38,44,000 equity shares (64.26% stake) in Kronox Lab Sciences Limited from selling promoters under the SPA dated 20th Aug'26. The sellers now retain 9.95% voting equity and cease to be promoters. Concurrently, Kronox overhauled its leadership: Suresh Kalra was appointed MD & CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO, alongside three new independent directors, following resignations of previous promoters and key management personnel.
Disclosure under Regulation 30, 30A and other applicable Provision of SEBI LODR read with Master Circular dated January 30, 2026
Change in Management · 30 Sept 2026, 12:03 am
Kronox Lab Sciences Completes 64.26% Stake Sale and Overhauls Leadership Sellers transferred a 64.26% stake (2.38 crore shares) in Kronox Lab Sciences to Indo Borax & Chemicals on 29th Sep'26, reducing their holding to 9.95% and relinquishing promoter status. Concurrently, the board completed a major leadership overhaul: Suresh Kalra was appointed MD & CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO, alongside three new independent directors. Erstwhile promoters resigned from executive roles and entered into 36-month transition consultancy agreements with the company for an aggregate fixed fee of ₹2.10 crore each.
Disclosure under Regulation 30, 30A and other applicable provisions of SEBI LODR read with Master Circular dated January 30, 2026
Change in Management · 30 Sept 2026, 12:00 am
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences Amid Leadership Overhaul Promoters of Kronox Lab Sciences transferred 2.38cr shares (64.26% equity) to Indo Borax & Chemicals and Zenrock Chemicals on 29th Sep'26, reducing their residual holding to 9.95% and declassifying them as promoters. Consequently, the board underwent complete reconstitution: Suresh Kalra was appointed Managing Director and CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO for 5-year terms. Outgoing promoters Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani resigned from executive roles and entered 36-month transition consultancy agreements worth INR 2.10cr each.
Disclosure under Regulation 30, Regulation 30A and other applicable provisions of SEBI LODR read with master circular dated January 30, 2026
Change in Management · 29 Sept 2026, 11:55 pm
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences Amid Leadership Overhaul Kronox Lab Sciences' promoters transferred 2,38,44,000 equity shares (64.26% stake) to Indo Borax & Chemicals Limited on 29th Sep'26, reducing seller holdings to 9.95% and reclassifying them out of the promoter group. Following the takeover, Suresh Kalra was appointed Managing Director and CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO, alongside a reconstituted board. Outgoing promoters Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani resigned from executive roles and entered into 36-month transition consultancy agreements at ₹2.10 crore each.
Disclosure under Regulation 30, 30A and other applicable provisions under SEBI (LODR) read with Master Circular dated January 30, 2026
Change in Management · 29 Sept 2026, 11:49 pm
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences Amid Leadership Overhaul Promoters of Kronox Lab Sciences completed the sale of a 64.26% stake (2,38,44,000 shares) to Indo Borax & Chemicals on 29th Sep'26, reducing their collective holding to 9.95% and ceasing to be promoters. Consequently, the board underwent a full overhaul: Suresh Kalra was appointed MD & CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO, alongside three new independent directors. Erstwhile promoter-directors resigned and entered 36-month transition consultancy agreements at an aggregate fee of INR 2.10 crore each.
Intimation under Regulation 31(A) of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 29 Sept 2026, 11:19 pm
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences, Launches Open Offer Indo Borax & Chemicals acquired 2,38,44,000 equity shares (64.26% stake) of Kronox Lab Sciences on 29th Sep'26, gaining sole control as the new promoter. The erstwhile promoter group's remaining aggregate stake reduced to 9.95% (36,90,000 shares), initiating reclassification to public category under SEBI regulations. Simultaneously, the acquirer along with PAC Zenrock Chemicals launched an open offer to acquire up to 95,70,000 equity shares (25.79% voting capital) from public shareholders.
Outcome of Board Meeting
Others (Uncategorized) · 29 Sept 2026, 11:04 pm
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences Amid Leadership Overhaul Kronox Lab Sciences announced that sellers transferred 2.38cr shares (a 64.26% stake) to Indo Borax & Chemicals on 29th Sep'26 under an SPA, reducing sellers' collective holding to 9.95% and terminating their promoter status. Consequently, previous promoter-directors and KMPs resigned, and the board appointed Suresh Kalra as MD & CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO for five-year terms. Additionally, the company entered 36-month transition consultancy agreements with outgoing promoter-executives for ₹2.10cr each.
Kronox Lab Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on September 29, 2026.
Outcome · 29 Sept 2026, 10:56 pm
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences Amid Complete Board Overhaul Promoters of Kronox Lab Sciences transferred a 64.26% stake (2,38,44,000 shares) to Indo Borax & Chemicals on 29th Sep'26, retaining 9.95% and ceding promoter status. Consequently, the company executed a leadership overhaul: outgoing MD Jogindersingh Jaswal, executive directors Ketan Ramani and Pritesh Ramani, and CFO Samir Gadhiya resigned. Suresh Kalra was appointed MD & CEO, and Shashikant Bharuka was named CFO for five-year terms. The three exiting promoters entered 36-month consultancy agreements for transition support, receiving ₹2.10 crore each.
Submission of Voting Results and Combined Scrutinizer''s Report for 17th Annual General Meeting held on September 16, 2026.
Annual General Meeting · 17 Sept 2026, 9:47 pm